Pharmacoeconomic Evaluation of Using One-Molar Gadolinium-Based Magnetic Resonance Contrast Agent Compared to Half-Molar Agents for the Diagnosis of Multiple Sclerosis

Pharmacoeconomic Evaluation of Using One-Molar Gadolinium-Based Magnetic Resonance Contrast Agent Compared to Half-Molar Agents for the Diagnosis of Multiple Sclerosis

Objective: to conduct a comparative assessment of the pharmacoeconomic advantages of using gadobutrol in comparison with half-molar (0.5 M) gadolinium chelates for the diagnosis of multiple sclerosis (MS).Material and methods. A calculator was developed in Microsoft Excel, in which the number of exa...

Full description

Bibliographic Details
Main Authors: A. A. Alikhanov, N. L. Shimanovskiy
Format: Article
Language:English
Published: LUCHEVAYA DIAGNOSTIKA, LLC 2020-11-01
Series:Вестник рентгенологии и радиологии
Subjects:
multiple sclerosis
magnetic resonance contrast agents
gadolinium-based contrast agents
one-molar drug
half-molar drug
gadobutrol
gadoteridol
gadodiamide
gadoteric acid
cost analysis
budget impact analysis
Online Access:https://www.russianradiology.ru/jour/article/view/594

Internet

https://www.russianradiology.ru/jour/article/view/594

Similar Items